Spontaneous Coronary Artery Dissection (SCAD): Yip-Saw Classification, Conservative Management, and Fibromuscular Dysplasia Screening
A comprehensive guideline to recognizing SCAD as the leading cause of MI in young women, navigating the conservative-first management strategy, and screening for fibromuscular dysplasia and other arteriopathies.
Executive Summary
Spontaneous coronary artery dissection (SCAD) is a non-traumatic, non-atherosclerotic separation of the coronary artery wall that creates an intramural hematoma compromising true lumen flow and causing acute myocardial infarction. It accounts for up to 25 percent of MIs in women under age 50 and is the leading cause of pregnancy-associated MI. Recognition turns on the Yip-Saw 2014 angiographic classification, with Type 2 (diffuse smooth narrowing from intramural hematoma) being most common and Type 3 frequently requiring intracoronary OCT or IVUS to distinguish from atherosclerotic disease. The management paradigm is conservative-first: percutaneous coronary intervention carries 40 to 50 percent complication rates in SCAD versus 5 to 10 percent in atherosclerotic disease, and the majority of SCAD lesions heal spontaneously. Beta-blocker therapy, fibromuscular dysplasia screening of the head, neck, abdomen, and pelvis, strict blood pressure control, and avoidance of estrogen-containing therapy and future peripartum SCAD are the pillars of secondary prevention.
Table of Contents
- Pathophysiology, Demographics, and Predisposing Conditions
- Yip-Saw Angiographic Classification and Diagnosis
- Conservative Management vs PCI vs CABG
- Fibromuscular Dysplasia Screening and Secondary Prevention
- Recurrence Risk, Cardiac Rehabilitation, and Pregnancy Counseling
- Practice Insights — Lessons from the Coronary Care Unit
- Frequently Asked Questions
S1. Pathophysiology, Demographics, and Predisposing Conditions
Spontaneous coronary artery dissection occurs when the coronary artery wall develops a non-traumatic separation between intima and media (or within the media), creating an intramural hematoma that compresses the true lumen and obstructs antegrade flow. Two pathophysiologic mechanisms are proposed: the inside-out hypothesis posits an intimal tear allowing blood from the true lumen to dissect into the wall, while the outside-in hypothesis posits primary rupture of a vasa vasorum within the media generating an intramural hematoma without an initial intimal tear. The outside-in mechanism appears more common based on optical coherence tomography studies showing intramural hematoma without visible intimal disruption in many SCAD cases.
Demographics and Predisposing Conditions
SCAD predominantly affects women aged 45 to 55 years (approximately 90 percent female, median age in mid-40s to mid-50s). The clinical profile is strikingly distinct from atherosclerotic ACS: typical SCAD patients have low atherosclerotic risk factor burden (no diabetes, minimal smoking, normal-to-mildly-elevated cholesterol) but disproportionate prevalence of arteriopathies, hormonal factors, and emotional or physical stress triggers.
| Predisposing Condition | Prevalence in SCAD | Clinical Implications |
|---|---|---|
| Fibromuscular dysplasia (FMD) | 50-80% | Most common SCAD association; screen entire arterial tree at diagnosis |
| Peripartum period (especially 1st month postpartum) | 5-10% of SCAD overall; majority of pregnancy-associated MI | Most severe SCAD phenotype; multivessel often; worst prognosis |
| Hormonal therapy (estrogen-containing OCP, HRT, fertility) | Substantial subgroup | Discontinue hormonal therapy after SCAD; counsel against re-initiation |
| Connective tissue disorders | 3-5% of SCAD | Ehlers-Danlos type 4 (vascular), Loeys-Dietz, Marfan; obtain genetic testing if features suggest |
| Systemic inflammatory disorders | 2-5% | SLE, PAN, RA, sarcoidosis — manage underlying disease |
| Migraine | Increased prevalence | Mechanistic links unclear; possibly shared vasculopathy |
| Extreme physical exertion as trigger | 30-50% report exertional trigger | Counsel against high-intensity isometric exercise |
| Emotional stress as trigger | 30-50% report stress trigger | Stress management counseling; consider psychological support |
Coronary Distribution
SCAD characteristically affects mid-to-distal segments of the coronary arteries (in contrast to atherosclerotic disease that favors proximal segments). The left anterior descending artery is the most commonly affected vessel (35 to 55 percent), followed by the circumflex, right coronary artery, and ramus intermedius. Left main involvement is uncommon but high-risk when present. Multivessel SCAD occurs in approximately 10 to 25 percent and is more common in peripartum SCAD.
The clinical presentation is acute coronary syndrome — chest pain with associated ECG changes (STEMI in 25 to 50 percent, NSTEMI in 50 to 75 percent) and troponin elevation. Approximately 5 to 10 percent present with ventricular arrhythmia or out-of-hospital cardiac arrest. Cardiogenic shock and significant heart failure are uncommon in first-event SCAD outside the peripartum population. Crucially, the demographic profile (young or middle-aged woman with chest pain and minimal atherosclerotic risk factors) should prompt explicit consideration of SCAD before defaulting to atherosclerotic ACS pathways.
S2. Yip-Saw Angiographic Classification and Diagnosis
Diagnosis of SCAD rests on coronary angiography supplemented by intracoronary imaging when needed. The Yip-Saw 2014 classification categorizes SCAD into three angiographic types that have direct implications for management.
| Type | Angiographic Appearance | Frequency | Comments |
|---|---|---|---|
| Type 1 | Multiple radiolucent lumens or contrast staining of arterial wall; classical “double lumen” or “flap” appearance | 10-30% | Most readily recognized; pathognomonic when present; cine angiography shows persistent contrast hang-up in false lumen |
| Type 2A | Diffuse, smooth narrowing greater than 20 mm with normal-caliber segments proximally and distally | ~50% | Most common; intramural hematoma; “tubular stenosis” between normal segments highly suggestive |
| Type 2B | Diffuse smooth narrowing extending to the distal tip of the vessel without normal distal segment | ~15% | Variant of Type 2; intramural hematoma extending distally |
| Type 3 | Focal or tubular stenosis less than 20 mm; mimics atherosclerosis | 10-20% | Most difficult to distinguish from atherosclerotic disease; intracoronary OCT or IVUS often required |
| Type 4 (proposed addition) | Total occlusion in young patient without atherosclerotic disease in other vessels | 5-10% | Recognized as SCAD when distal vessel reconstitutes during conservative management |
When to Use Intracoronary Imaging
Optical coherence tomography (OCT) and intravascular ultrasound (IVUS) provide high-resolution intracoronary imaging that can definitively confirm SCAD when angiography is equivocal. OCT has spatial resolution of approximately 10-20 micrometers and clearly visualizes intramural hematoma, intimal flaps, and true vs false lumen. IVUS has lower resolution but provides deeper tissue penetration and is preferred when extensive intramural hematoma may compromise OCT image quality. Indications for intracoronary imaging include:
- Ambiguous angiographic appearance (Type 3 SCAD; differentiation from atherosclerotic plaque rupture)
- Young patient (less than age 50) with apparent ACS and equivocal angiography
- Pre-PCI assessment when revascularization is being considered for SCAD
- Suspected left main involvement
Differential Diagnosis
| Alternative Diagnosis | Distinguishing Feature | Decisive Test |
|---|---|---|
| Atherosclerotic ACS | Proximal calcified plaque; multi-vessel disease; high risk factor burden | Angiographic pattern + calcium scoring + lipid profile |
| Coronary embolism | Abrupt cutoff of normal-appearing vessel; embolic source (AF, valve, IE) | TEE + echocardiography + arrhythmia monitoring |
| Coronary vasospasm (Prinzmetal) | Transient focal narrowing relieved by intracoronary NTG | Intracoronary NTG response; provocation testing with acetylcholine |
| Myocardial bridging | Systolic compression of an epicardial vessel coursing intramyocardially | Dynamic angiographic narrowing during systole that resolves in diastole |
| Coronary vasculitis (Kawasaki, Takayasu, GCA) | Aneurysm formation, systemic inflammation, age extremes | Inflammatory markers + extracoronary imaging + sometimes biopsy |
| MINOCA (other) | Myocardial infarction with non-obstructed coronary arteries; CMR for myocarditis vs takotsubo | Cardiac MRI for tissue characterization |
S3. Conservative Management vs PCI vs CABG
The Conservative-First Paradigm
The single most important management decision in SCAD is to NOT default to immediate PCI as one would in atherosclerotic ACS. The natural history of conservatively managed SCAD shows that the majority of lesions heal spontaneously over weeks to months, while PCI in the SCAD vessel carries a 40 to 50 percent technical complication rate (vessel extension, distal embolization, propagation of dissection, false lumen entry with wires). The conservative approach involves admission to a coronary care unit, telemetry, anti-anginal therapy, and serial imaging to confirm healing.
Indications for Revascularization Despite SCAD
Revascularization (PCI or CABG) is reserved for situations where the risk of leaving the dissected vessel unrevascularized exceeds the procedural risk. These indications include:
- Ongoing ischemia despite anti-anginal therapy (persistent chest pain, ST elevation, hemodynamic instability)
- Ventricular arrhythmia attributable to ongoing ischemia (recurrent VT/VF)
- Left main SCAD or proximal LAD with critical hemodynamic significance
- TIMI 0-1 flow with extensive territory at risk (large infarct in evolution)
- Cardiogenic shock attributable to the dissected vessel
When PCI is Performed for SCAD — Technical Considerations
- Cutting balloon angioplasty or low-pressure balloon dilation to fenestrate the intramural hematoma may relieve compression without stent placement and is increasingly preferred for selected cases
- If stenting is required, use the longest possible stent to cover the entire dissection plus 5 to 10 mm proximally and distally to prevent propagation
- Consider bioresorbable stents when available given the typically young patient population and concern about long-term stent thrombosis
- Use OCT or IVUS guidance to confirm wire position in true lumen before any ballooning or stenting
- If wire cannot be confidently advanced into the true lumen distal to the dissection, abort PCI rather than risk false lumen extension
CABG Indications
Coronary artery bypass grafting is rarely the first-line approach but may be appropriate for:
- Left main SCAD with failed PCI
- Multivessel SCAD with cardiogenic shock
- SCAD where the dissection extends to the distal vessel making PCI technically infeasible
CABG outcomes in SCAD are reasonable, though long-term graft patency may be inferior to atherosclerotic CABG because the native artery often heals and competes with the graft. Internal mammary artery grafts are preferred when feasible.
Acute Pharmacotherapy
| Medication | SCAD Recommendation | Rationale |
|---|---|---|
| Beta-blocker | Recommended for essentially all SCAD survivors (metoprolol succinate 25-50 mg daily, titrate to HR 60-70 bpm) | Reduces recurrence by ~64% in observational data; reduces wall shear stress |
| Aspirin | Often used at conservative dose (81 mg daily) during acute phase; long-term role unclear | Theoretical antiplatelet benefit; no SCAD-specific evidence |
| Dual antiplatelet therapy (DAPT) | NOT routinely recommended unless stent placed; if conservative management, single antiplatelet acceptable | DAPT may worsen intramural hematoma and bleeding; reserved for stented segments |
| Anticoagulation (heparin, LMWH) | Discontinue once SCAD recognized unless other indication | May extend dissection and intramural hematoma |
| ACE inhibitor / ARB | Only if reduced LVEF (less than 40%) or hypertension; not routine | No SCAD-specific evidence for routine use without indication |
| Statin | NOT routinely recommended unless LDL elevated or atherosclerotic disease present | SCAD is non-atherosclerotic; statins do not modify recurrence |
| Nitrates | Useful for anti-anginal symptom control during acute phase | Symptomatic relief; long-term role unclear |
S4. Fibromuscular Dysplasia Screening and Secondary Prevention
FMD Screening — Why and How
Fibromuscular dysplasia is identified in 50 to 80 percent of SCAD patients on dedicated extracoronary arterial imaging, often involving the renal, carotid, vertebral, or visceral arteries. Identifying extracoronary FMD has direct implications for monitoring and prevention of stroke, refractory hypertension, mesenteric ischemia, and arterial aneurysm. Screening is recommended for every SCAD patient at the time of diagnosis or shortly after stabilization.
| Screening Modality | Anatomic Coverage | Recommendation |
|---|---|---|
| CT angiography head, neck, abdomen, pelvis | Carotid, vertebral, intracranial, renal, mesenteric, iliac arteries | Standard screening protocol; single contrast bolus across multiple stations |
| MR angiography (alternative) | Same anatomic coverage | Preferred if iodinated contrast allergy or impaired renal function |
| Catheter angiography | Targeted vessels | Reserved for intervention or when CTA/MRA is non-diagnostic |
| Renal artery Doppler ultrasound | Renal arteries only | Supplementary; may detect renal FMD when CTA equivocal |
FMD Findings That Modify Management
- Renal FMD with refractory hypertension — consider renal artery angioplasty for blood pressure control
- Carotid or vertebral FMD with aneurysm — surveillance imaging and consideration of intervention if symptomatic or large
- Intracranial aneurysm (5 to 10 percent of FMD patients) — neurosurgical consultation
- Mesenteric FMD — counsel patient on mesenteric ischemia symptoms; consider follow-up imaging
Secondary Prevention Pillars
- Beta-blocker therapy — essentially all SCAD survivors; titrate to HR 60-70 bpm (metoprolol succinate 25-50 mg daily typical starting dose, may need 100-200 mg daily for adequate rate control)
- Blood pressure control — target less than 130/80 mmHg; ACE inhibitor or ARB if hypertension present; calcium channel blocker as add-on if needed
- Discontinuation of estrogen-containing hormonal therapy — OCPs, postmenopausal HRT, fertility therapy; switch to non-hormonal contraception (IUD, condoms) for women of reproductive age
- Activity modification — avoid extreme isometric exercise (heavy weightlifting greater than 20 kg, sprinting, competitive contact sports); encourage moderate aerobic exercise and cardiac rehabilitation
- Stress management — counseling, psychological support, and consideration of cognitive behavioral therapy when emotional stress was identified as trigger
- Pregnancy counseling — discourage future pregnancy after peripartum SCAD; counsel on recurrence risk for non-peripartum SCAD planning pregnancy
- Connective tissue genetic testing — when systemic features (joint hypermobility, skin findings, family history of arterial events) suggest hereditary arteriopathy
S5. Recurrence Risk, Cardiac Rehabilitation, and Pregnancy Counseling
Recurrence Risk
Recurrent SCAD occurs in approximately 10 to 30 percent of patients over 3 to 5 years, with peripartum SCAD and untreated hypertension being the strongest risk factors. Recurrence may involve the same or a different coronary artery, and the recurrent event can be more severe than the index event. The 10-year recurrence rate may be substantially higher (some series report 40 percent or more). Predictors of recurrence include:
- Peripartum SCAD at index event
- Multivessel SCAD at index event
- Untreated hypertension
- Persistence of FMD with progressive findings
- Connective tissue disorder
- Continued use of estrogen-containing hormonal therapy
- Continued high-intensity isometric exercise
Cardiac Rehabilitation
Cardiac rehabilitation is recommended for essentially all SCAD survivors but must be modified from traditional atherosclerotic ACS rehabilitation. Specific modifications:
- Avoid high-intensity isometric exercise (heavy weightlifting, plyometrics, sprinting)
- Focus on moderate-intensity aerobic exercise (walking, swimming, stationary cycling)
- Continuous heart rate monitoring during exercise with target heart rate 60-80 percent of age-predicted maximum
- Psychological support integrated — SCAD survivors often experience high anxiety and depression rates
- Return-to-work counseling — office work generally resumed at 4-6 weeks; physically demanding work may require occupational reassessment
Pregnancy and SCAD
Pregnancy carries elevated recurrence risk after SCAD, with peripartum SCAD recurrence reported in 10 to 35 percent in subsequent pregnancies. Counseling principles:
- After peripartum SCAD — counsel against future pregnancy. The recurrence risk is high and the consequences potentially catastrophic; expert consensus supports recommending against future pregnancy specifically after a peripartum SCAD event.
- After non-peripartum SCAD — pregnancy discouraged for at least 12 months following the index event to allow coronary healing; subsequent pregnancy individualized based on coronary healing status (repeat angiography to confirm), residual ventricular function, FMD severity, and patient preference.
- For patients who proceed with pregnancy — multidisciplinary cardio-obstetrics care with serial echocardiography, careful blood pressure management, consideration of cesarean delivery to limit Valsalva stress (though shortened vaginal delivery is appropriate in many).
- Postpartum monitoring — the first month postpartum is highest risk; consider extended monitoring with telemetry and threshold for repeat angiography for any chest pain symptom.
Long-Term Follow-Up Schedule
| Time Point | Assessment |
|---|---|
| 1 week | Symptom check, blood pressure, beta-blocker tolerance |
| 1 month | Echocardiogram for LVEF, repeat blood pressure, FMD imaging if not yet done |
| 3 months | Consider repeat coronary angiography or coronary CT to assess healing in patients managed conservatively; cardiac rehabilitation progress |
| 6-12 months | Annual cardiology visit, symptom-based; repeat imaging only if symptomatic |
| Long-term (annual) | Symptom review, blood pressure, FMD surveillance, repeat extracoronary imaging every 2-3 years |
S6. Practice Insights — Lessons from the Coronary Care Unit
1. The angiographic pattern in a young woman is the diagnostic moment
When the angiogram in a woman in her 40s or 50s shows a long smooth tubular narrowing between normal-caliber proximal and distal segments, experienced practice now is to pause the procedure, share the image with a SCAD-experienced colleague, and resist any reflex to advance a wire across the lesion. The Yip-Saw Type 2A pattern is so classical in this demographic that the diagnosis is essentially made on the cine, and the worst error is to engage the vessel with a wire and convert a healing-prone Type 2 into an iatrogenic extension. The practical rule: in any woman under 60 with apparent ACS and equivocal angiography, think SCAD first and atherosclerosis second.
2. The conservative-first paradigm requires institutional support, not just a guideline
The single hardest part of SCAD management in clinical experience is convincing the interventional cardiology team and the broader CCU culture to NOT stent a non-occlusive dissected vessel in a stable patient. The institutional reflex with any ACS angiogram showing significant narrowing is to revascularize, and overriding that reflex requires explicit pre-procedure conversation with the operator about SCAD probability and management plan. Experienced practice is to flag SCAD suspicion in the procedure note BEFORE the angiogram if the demographic and presentation suggest it, so the operator has a primed alternative framework ready.
3. The FMD screening is the most often skipped follow-up step
In clinical experience, the FMD screening (CT angiography of the head, neck, abdomen, and pelvis) is the most often skipped post-SCAD step, especially when the patient is discharged stable and the focus shifts to outpatient cardiac rehabilitation. Yet 50 to 80 percent of SCAD patients have FMD on dedicated imaging, and identifying renal FMD with subclinical hypertension or carotid FMD with subclinical aneurysm changes long-term management. The standard order set now includes the FMD CTA scheduled before discharge, with a follow-up vascular medicine consultation if abnormal.
4. The psychological reframing is as important as the medical management
SCAD patients arrive convinced they have heart disease in the atherosclerotic sense and that their life is over — this framing is reinforced by every “MI” label on their chart and by well-intentioned but inappropriate counseling about cholesterol, diet, and traditional risk factors. In experienced practice, the most valuable conversation with the patient and family is the explicit explanation that SCAD is a non-atherosclerotic, non-lifestyle-driven condition, that recurrence risk is real but modifiable with beta-blocker and stress management rather than statin and aspirin, and that they can return to a substantially normal life with specific activity modifications. This conversation reduces post-SCAD anxiety, improves medication adherence, and shapes engagement with cardiac rehabilitation.
Personal protocol adjustments beyond the published guideline
- Flag SCAD suspicion in the cath lab BEFORE angiography in young women with apparent ACS. Experienced practice is to communicate the SCAD hypothesis to the interventional cardiologist before the angiogram begins, so the operator has a primed conservative-first framework rather than defaulting to PCI reflexively. The pre-conversation has changed outcomes in experienced hands more than any post-angiogram reasoning.
- Stop heparin and reconsider DAPT as soon as SCAD is recognized angiographically. The reflexive anticoagulation and DAPT for “MI” can extend intramural hematoma and worsen the clinical course. The standard now is to halt the heparin infusion immediately and de-escalate to single antiplatelet therapy unless a stent has been placed.
- FMD CT angiography scheduled before discharge, not deferred to outpatient. Deferring FMD screening to outpatient follow-up means it often does not get done. The order set now includes the head-neck-abdomen-pelvis CTA scheduled during the inpatient stay as a standard component of SCAD admission.
- Explicit reframing conversation with patient and family on day 1 or 2. The most important intervention beyond medical management is the explicit conversation that SCAD is a non-atherosclerotic, non-lifestyle-driven condition with specific (not generic) prevention strategies. Experienced clinicians schedule this conversation early in the hospital stay rather than at discharge to shape engagement with the entire treatment plan.
Four-panel personal framework: Yip-Saw angiographic classification with mid-to-distal LAD predilection (panel 1), demographic contrast against atherosclerotic ACS that should drive SCAD suspicion in young women (panel 2), conservative-first decision tree with explicit high-risk criteria for revascularization (panel 3), and the seven secondary prevention pillars seasoned clinicians apply to every SCAD survivor (panel 4). Approximate ranges; not institutional outcome data.
S7. Frequently Asked Questions
- Aortic Dissection: Stanford Classification, Imaging Triage, and Urgent Surgical and Medical Management
- Arrhythmogenic Right Ventricular Cardiomyopathy: Diagnosis, ICD Decision, and Family Screening
- Tricuspid Regurgitation: Diagnosis and Management
- Aortic Stenosis: Diagnosis, Staging, and Management
- Mitral Regurgitation: Primary vs Secondary, Imaging, and TEER Indications
- Aortic Regurgitation: ACC/AHA Diagnosis, Echo Severity Grading, and Surgical Timing